Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant <i>Helicobacter pylori</i> Infection: Effectiveness and Cost-Efficiency.

Lee, Moon Won; Kim, Gwang Ha

Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Helicobacter pylori Infection: Effectiveness and Cost-Efficiency.

Lee, Moon Won; Kim, Gwang Ha.

Affiliation

Lee MW; Department of Internal Medicine, Pusan National University College of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
Kim GH; Department of Internal Medicine, Pusan National University College of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.

Gut Liver ; 16(6): 807-808, 2022 11 15.

Article in En | MEDLINE | ID: mdl-36379903

Subject(s)

Helicobacter Infections; Helicobacter pylori; Humans; Bismuth/therapeutic use; Clarithromycin/therapeutic use; Helicobacter Infections/drug therapy; Amoxicillin/therapeutic use; Anti-Bacterial Agents/therapeutic use; Drug Therapy, Combination; Proton Pump Inhibitors/therapeutic use; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Helicobacter pylori / Helicobacter Infections Type of study: Health_economic_evaluation Limits: Humans Language: En Journal: Gut Liver Year: 2022 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google